94% overturnedAppeal outcomes · Injections

Denied hyaluronic acid knee injection: what independent reviewers actually decided

Of every procedure in this corpus, the injection series for knee osteoarthritis is the one independent reviewers reversed most often — and the reason is unusually consistent.

A course of hyaluronic acid injected into the knee joint for osteoarthritis, billed by the treating physician under the drug's own supply code with a separate administration code. Plans commonly route it through a medical-benefit prior authorization even though the patient never touches a pharmacy.

What the independent reviewers decided

94%

overturned by the independent reviewer

792

of 844 decisions in the corpus

Source

California DMHC independent medical review determinations, 2017-2026. Public record.

Read this as a base rate, not as your odds

These are decisions about other patients, in one state, that had already been through the plan's own internal appeal and were then sent to an outside reviewer. That population is self-selected toward disputes worth pursuing, so the rate says what happened to cases like this at that stage — not what will happen to a specific claim. It is not medical or legal advice.

Why plans deny hyaluronic acid knee injection

  • The plan classes the series as not medically necessary because its policy treats the evidence for symptomatic relief as insufficient.
  • The record does not show a documented trial of the specific conservative measures the policy names, in the order it names them.
  • A repeat series is denied for interval — the policy sets a minimum months-since-last-course that the claim does not meet.
  • The knee is graded radiographically as too advanced, and the policy redirects to arthroplasty.

What actually carried the cases that won

Prior treatment carried the overturned cases by a wide margin. What separated a reversal from an affirmation was rarely a novel clinical argument — it was a record that named each conservative measure already tried, for how long, and what happened. Where the file listed the analgesics, the therapy course and the prior injections with dates and outcomes, the reviewer had the finding it needed. Where it asserted that conservative care had failed without itemising it, the plan's policy stood.

What the record showedShare of overturned decisions
Prior treatment was documented88%
A published guideline supported the request84%
Conservative treatment was documented as failed57%
The condition was documented as chronic or long-standing34%
The functional impact on the patient was documented14%
Objective findings were documented13%
The severity or urgency was documented13%
The diagnosis was confirmed10%

Shares are of the overturned decisions and do not sum to 100% — a single decision often rested on more than one, and some rested on none of these.

What the reviewers cited

  • Peer-reviewed literature — in 85% of the overturned decisions
  • Clinical guidelines — in 67% of the overturned decisions
  • Specialty-society criteria — in 62% of the overturned decisions
  • Standard of care — in 0% of the overturned decisions
  • FDA labeling — in 0% of the overturned decisions

hyaluronic acid knee injection denials — frequently asked

Is a denied hyaluronic acid injection worth appealing?
In California's independent-review corpus, 94% of these denials were overturned across 844 decisions — the highest rate of any procedure we track. That is a base rate for cases that reached an outside reviewer after the plan upheld its own denial, not a prediction for a specific claim, but it is a strong signal that these denials do not survive neutral review well.
What does the reviewer want to see in the record?
Prior treatment, itemised. Name each conservative measure, the dates, the duration and the result — analgesics, physical therapy, corticosteroid injection, activity modification. A blanket statement that conservative care failed is the most common weakness in the files that were not overturned.
Does the radiographic grade of the knee matter?
It can. Some plan policies exclude a knee graded as end-stage on the theory that the appropriate treatment is arthroplasty. Where that is the stated reason, the appeal has to address the grading and why the injection is appropriate for this patient now — not only that conservative care failed.

Related guides

CO-50 — not medically necessaryMedical necessity appeal lettersHow external review works

Source

Denial reasons and criteria are described in plain language for reference and vary by plan and policy. This page reports what independent reviewers decided in a public California dataset; it is general information, not medical, legal, or coverage advice.

When the appeal has to be written, and cited

Upload the denied EOB and Merits returns a complete, citation-verified appeal letter — the clinical argument, the payer's own coverage criteria, and your federal appeal rights — in about a minute.

Appeal a denial →